Tetraphase Pharmaceuticals, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 51
Rang # Quantité totale PI 26 945
Note d'activité PI 1,9/5.0    13
Rang # Activité PI 67 083
Symbole boursier TTPH (nasdaq)
ISIN US88165N1054
Capitalisation 16.10M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

12 6
3 5
15 5
5
 
Dernier brevet 2025 - C7-fluoro substituted tetracycli...
Premier brevet 2009 - C7-fluoro substituted tetracycli...
Dernière marque 2021 - XERAVA
Première marque 2015 - TETRAPHASE PHARMACEUTICALS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention C7-fluoro substituted tetracycline compounds. The present invention is directed to a compound re...
2023 Invention Crystalline forms of eravacycline. The invention relates to crystalline forms of the bis-HCl sal...
2022 P/S Pharmaceutical preparations, namely, antibiotics.
2021 P/S Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforemention...
Invention Crystalline forms of eravacycline. The invention relates to crystalline forms of the bis-HCl salt...
2020 Invention Tetracycline compounds for the treatment of hematological cancers. This invention relates to a me...
2019 Invention Polymorphic forms of a compound and uses thereof. The invention relates to crystalline forms of ...
Invention Polymorphic forms of a compound and uses thereof. The invention relates to crystalline forms of t...
Invention Tetracycline compounds. The present invention is directed to a compound represented by Structural...
2018 Invention Semi-synthesis procedures. Provided herein are improved processes for converting C7-amino-substit...
P/S Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementione...
P/S Pharmaceuticals, namely antibiotics indicated for the treatment of infections; the aforementioned...
P/S Pharmaceutical preparations, namely, antibiotics.
P/S Pharmaceutical preparations, namely, antibiotics
Invention Tetracycline compounds. The present invention is directed to a compound represented by Structura...
2017 Invention Crystalline forms of eravacycline. The invention relates to crystalline forms of the bis-HCI salt...
Invention Tetracycline compounds and methods of treatment. The present invention is directed to methods of...
Invention Tetracycline compounds and methods of treatment. The present invention is directed to methods of ...
Invention Tetracyline compounds. The present invention is directed to a compound represented by Structural ...
2016 Invention Preparation of mixed amidomagnesium halides. A composition, comprising an amidomagnesium chloride...
P/S Pharmaceutical preparations.
Invention Polycyclic tetracycline compounds. The present invention is directed to a compound represented b...
P/S Pharmaceutical preparations, namely antibiotics
2015 Invention Semi-synthesis procedures. Provided herein are improved processes for convening C7-amino-substitu...
Invention Semi-synthesis procedures. Provided herein are improved processes tor convening C7-amino-substitu...
P/S Pharmaceutical preparations, namely, antibiotics
2012 Invention 8-aza tetracycline compounds. The present invention is directed to a compound represented by Stru...
Invention C7-fluoro substituted tetracycline compounds. The present invention is directed to a compound rep...
2011 Invention Methods of treating bacterial infections. The invention relates to a method of treating a bacteri...
Invention Tetracycline analogs. The present invention is directed to a compound represented by Structural F...
Invention Polycyclic tetracycline compounds. The present invention is directed to a compound represented by...
2010 Invention Pentacycline compounds. The present invention is directed to a compound represented by Structura...
Invention Pentacycline compounds. The present invention is directed to a compound represented by Structural...